Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis

Regorafenib showed promising results as a second-line agent after sorafenib failure in hepatocellular carcinoma patients. The aim of this meta-analysis was to evaluate the efficacy and safety of regorafenib in hepatocarcinoma patients. A computerized bibliographic search was performed on the main da...

Descripción completa

Detalles Bibliográficos
Autores principales: Facciorusso, Antonio, Abd El Aziz, Mohamed A., Sacco, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017079/
https://www.ncbi.nlm.nih.gov/pubmed/31877664
http://dx.doi.org/10.3390/cancers12010036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017079/
https://www.ncbi.nlm.nih.gov/pubmed/31877664
http://dx.doi.org/10.3390/cancers12010036

Ejemplares similares